{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:26:44Z","timestamp":1786955204198,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013061","name":"Jilin Provincial Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20250206008ZP"],"award-info":[{"award-number":["20250206008ZP"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Phys"],"DOI":"10.1186\/s40658-026-00845-9","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:34:50Z","timestamp":1770525290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of external dose rate attenuation and its related factors in differentiated thyroid carcinoma patients following I-131 therapy"],"prefix":"10.1186","volume":"13","author":[{"given":"Zimeng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-5850","authenticated-orcid":false,"given":"Shuman","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"845_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1089\/thy.2017.0129","volume":"29","author":"M Luster","year":"2019","unstructured":"Luster M, Aktolun C, Amendoeira I, Barczy\u0144ski M, Bible KC, Duntas LH, et al. European perspective on 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: proceedings of an interactive international symposium. Thyroid. 2019;29:7\u201326. https:\/\/doi.org\/10.1089\/thy.2017.0129.","journal-title":"Thyroid"},{"key":"845_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Nat Cancer Center. 2024;4:47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Nat Cancer Center"},{"key":"845_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2967\/jnumed.121.262402","volume":"63","author":"AM Avram","year":"2022","unstructured":"Avram AM, Zukotynski K, Nadel HR, Giovanella L. Management of differentiated thyroid cancer: the standard of care. J Nucl Med. 2022;63:189\u201395. https:\/\/doi.org\/10.2967\/jnumed.121.262402.","journal-title":"J Nucl Med"},{"key":"845_CR4","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892\u20139. https:\/\/doi.org\/10.1210\/jc.2005-2838.","journal-title":"J Clin Endocrinol Metab"},{"key":"845_CR5","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.12659\/msm.899028","volume":"22","author":"Y He","year":"2016","unstructured":"He Y, Pan MZ, Huang JM, Xie P, Zhang F, Wei LG. Iodine-131: an effective method for treating lymph node metastases of differentiated thyroid cancer. Med Sci Monit. 2016;22:4924\u20138. https:\/\/doi.org\/10.12659\/msm.899028.","journal-title":"Med Sci Monit"},{"key":"845_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40266-015-0256-y","volume":"32","author":"DS McLeod","year":"2015","unstructured":"McLeod DS, Carruthers K, Kevat DA. Optimal differentiated thyroid cancer management in the elderly. Drugs Aging. 2015;32:283\u201394. https:\/\/doi.org\/10.1007\/s40266-015-0256-y.","journal-title":"Drugs Aging"},{"key":"845_CR7","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20180136","volume":"91","author":"PS Choudhury","year":"2018","unstructured":"Choudhury PS, Gupta M. Differentiated thyroid cancer theranostics: radioiodine and beyond. Br J Radiol. 2018;91:20180136. https:\/\/doi.org\/10.1259\/bjr.20180136.","journal-title":"Br J Radiol"},{"key":"845_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0002-9343(81)90573-8","volume":"70","author":"EL Mazzaferri","year":"1981","unstructured":"Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year foliow-up report of the impact of therapy in 576 patients. Am J Med. 1981;70:511\u20138. https:\/\/doi.org\/10.1016\/0002-9343(81)90573-8.","journal-title":"Am J Med"},{"key":"845_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/hp.0000000000001063","volume":"117","author":"C Karo","year":"2019","unstructured":"Karo C, Ideguchi R, Nishi K, Fukuda N, Miura M, Matuda N, et al. Radiation monitoring of an isolation room for 131I therapy after the patients were released. Health Phys. 2019;117:419\u201325. https:\/\/doi.org\/10.1097\/hp.0000000000001063.","journal-title":"Health Phys"},{"key":"845_CR10","unstructured":"Agency IAE. Radiation Protection and Safety in Medical Uses of Ionizing Radiation. https:\/\/www-pub.iaea.org\/MTCD\/Publications\/PDF\/PUB1775_web.pdf; 2018."},{"key":"845_CR11","doi-asserted-by":"publisher","unstructured":"RADIOLOGICALP ICO. Release of patients after therapy with unsealed radionuclides. Ann ICRP. 2004; 34: v\u2013vi, 1\u201379. https:\/\/doi.org\/10.1016\/j.icrp.2004.08.001.","DOI":"10.1016\/j.icrp.2004.08.001"},{"key":"845_CR12","unstructured":"China NHCotPsRo. Requirements for radiological protection in nuclear medicine. https:\/\/www.nhc.gov.cn\/cms-search\/downFiles\/657e04bc556e428db6db6f4bc98191a7.pdf; 2021."},{"key":"845_CR13","unstructured":"China MoEaEotPsRo. Radiation protection and safety requirements for nuclear medicine. Ministry of Ecology and Environment of the People's Republic of China. https:\/\/www.mee.gov.cn\/ywgz\/fgbz\/bz\/bzwb\/hxxhj\/xgbz\/202109\/W020210922368889711824.pdf; 2021."},{"key":"845_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/thy.2017.0570","volume":"29","author":"P Li","year":"2019","unstructured":"Li P, Zhang A, Liu Y, Xu C, Tang L, Yuan H, et al. Radioactive iodine therapy in patients with differentiated thyroid cancer: study of external dose rate attenuation law and individualized patient management. Thyroid. 2019;29:93\u2013100. https:\/\/doi.org\/10.1089\/thy.2017.0570.","journal-title":"Thyroid"},{"key":"845_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2967\/jnmt.120.246512","volume":"49","author":"P de Paolo Barros","year":"2021","unstructured":"de Paolo Barros P, Cagol Camozzato TS, Jahn T, Penna Soares FA, da Machado Silva L, de Aguiar Soares J, et al. Analysis of radiometry on patients undergoing radioactive iodine therapy. J Nucl Med Technol. 2021;49:75\u201381. https:\/\/doi.org\/10.2967\/jnmt.120.246512.","journal-title":"J Nucl Med Technol"},{"key":"845_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid"},{"key":"845_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.ijo.0803354","volume":"31","author":"Y Wang","year":"2007","unstructured":"Wang Y, Mi J, Shan XY, Wang QJ, Ge KY. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes. 2007;31:177\u201388. https:\/\/doi.org\/10.1038\/sj.ijo.0803354.","journal-title":"Int J Obes"},{"key":"845_CR18","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s002590050185","volume":"24","author":"SF Barrington","year":"1997","unstructured":"Barrington SF, Kettle AG, O\u2019Doherty MJ, Wells CP, Somer EJR, Coakley AJ. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur J Nucl Med. 1997;24:1545. https:\/\/doi.org\/10.1007\/s002590050185.","journal-title":"Eur J Nucl Med"},{"key":"845_CR19","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u201386. https:\/\/doi.org\/10.1002\/ijc.29210.","journal-title":"Int J Cancer"},{"key":"845_CR20","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20200700","volume":"94","author":"A Al-Jabri","year":"2021","unstructured":"Al-Jabri A, Cooke J, Cournane S, Healy ML. Gender differences in estimating I-131 thyroid uptake from Tc-99m thyroid uptake for benign thyroid disease. Br J Radiol. 2021;94:20200700. https:\/\/doi.org\/10.1259\/bjr.20200700.","journal-title":"Br J Radiol"},{"key":"845_CR21","first-page":"73","volume":"44","author":"J Xian","year":"2020","unstructured":"Xian J, Wu J, Lu J, Ouyang W, Feng H, Chen P. Factors of radiation dose rates and hospitalization days for papillary thyroid cancer patients with after first 131I therapy. Int J Radiat Med Nucl Med. 2020;44:73\u201380.","journal-title":"Int J Radiat Med Nucl Med"},{"key":"845_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000007942","volume":"96","author":"SF Kuo","year":"2017","unstructured":"Kuo SF, Ho TY, Liou MJ, Lin KJ, Cheng RC, Chan SC, et al. Higher body weight and distant metastasis are associated with higher radiation exposure to the household environment from patients with thyroid cancer after radioactive iodine therapy. Medicine. 2017;96:e7942. https:\/\/doi.org\/10.1097\/md.0000000000007942.","journal-title":"Medicine"},{"key":"845_CR23","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1089\/thy.2019.0699","volume":"30","author":"JH Park","year":"2020","unstructured":"Park JH, Choi M, Kim JH, Kim J, Han K, Kim B, et al. Metabolic syndrome and the risk of thyroid cancer: a nationwide population-based cohort study. Thyroid. 2020;30:1496\u2013504. https:\/\/doi.org\/10.1089\/thy.2019.0699.","journal-title":"Thyroid"},{"key":"845_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph21060757","author":"Y Wu","year":"2024","unstructured":"Wu Y, Li D, Vermund SH. Advantages and limitations of the body mass index (BMI) to assess adult obesity. Int J Environ Res Public Health. 2024. https:\/\/doi.org\/10.3390\/ijerph21060757.","journal-title":"Int J Environ Res Public Health"},{"key":"845_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12020-017-1394-2","volume":"60","author":"S Buscemi","year":"2018","unstructured":"Buscemi S, Massenti FM, Vasto S, Galvano F, Buscemi C, Corleo D, et al. Association of obesity and diabetes with thyroid nodules. Endocrine. 2018;60:339\u201347. https:\/\/doi.org\/10.1007\/s12020-017-1394-2.","journal-title":"Endocrine"},{"key":"845_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40708-1","volume":"9","author":"SJ Kim","year":"2019","unstructured":"Kim SJ, Kim MJ, Yoon SG, Myong JP, Yu HW, Chai YJ, et al. Impact of smoking on thyroid gland: dose-related effect of urinary cotinine levels on thyroid function and thyroid autoimmunity. Sci Rep. 2019;9:4213. https:\/\/doi.org\/10.1038\/s41598-019-40708-1.","journal-title":"Sci Rep"},{"key":"845_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2265.2004.02060.x","volume":"61","author":"CF Eustatia-Rutten","year":"2004","unstructured":"Eustatia-Rutten CF, Smit JW, Romijn JA, van der Kleij-Corssmit EP, Pereira AM, Stokkel MP, et al. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clin Endocrinol. 2004;61:61\u201374. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02060.x.","journal-title":"Clin Endocrinol"},{"key":"845_CR28","unstructured":"Yi W, Yuan X, Cai H, Liu J, Zhang Q, Fan S, et al. Prediction model of radiation dose in patients with differentiated thyroid cancer after 131I treatment. Int J Radiat Med Nucl Med. 2022; 67\u201372."},{"key":"845_CR29","first-page":"721","volume":"40","author":"Y Ji","year":"2020","unstructured":"Ji Y, Zheng W, Tan J, Wang R. Residual radioactivity and its influencing factors in patients with differentiated thyroid carcinoma after 131I therapy. Chin J Nucl Med Mol Imaging. 2020;40:721\u20135.","journal-title":"Chin J Nucl Med Mol Imaging"},{"key":"845_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00411-018-0736-7","volume":"57","author":"P Jin","year":"2018","unstructured":"Jin P, Feng H, Ouyang W, Wu J, Chen P, Wang J, et al. Radiation dose rates of differentiated thyroid cancer patients after (131)I therapy. Radiat Environ Biophys. 2018;57:169\u201377. https:\/\/doi.org\/10.1007\/s00411-018-0736-7.","journal-title":"Radiat Environ Biophys"},{"key":"845_CR31","first-page":"354","volume":"43","author":"JA Siegel","year":"2002","unstructured":"Siegel JA, Kroll S, Regan D, Kaminski MS, Wahl RL. A practical methodology for patient release after tositumomab and (131)I-tositumomab therapy. J Nucl Med. 2002;43:354\u201363.","journal-title":"J Nucl Med"},{"key":"845_CR32","doi-asserted-by":"publisher","DOI":"10.12659\/msm.928796","volume":"27","author":"F Yu","year":"2021","unstructured":"Yu F, Zhang R, Zhang G, Meng Z, Liu X, He Y, et al. Predictive value of a thyroid-absorbed dose with a shorter effective half-life on efficacy in graves disease patients receiving iodine-131 therapy. Med Sci Monit. 2021;27:e928796. https:\/\/doi.org\/10.12659\/msm.928796.","journal-title":"Med Sci Monit"},{"key":"845_CR33","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.Epi-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"Kitahara CM, Schneider AB. Epidemiology of thyroid cancer. Cancer Epidemiol Biomarkers Prev. 2022;31:1284\u201397. https:\/\/doi.org\/10.1158\/1055-9965.Epi-21-1440.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"845_CR34","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1245\/s10434-011-2129-x","volume":"19","author":"HS Kazaure","year":"2012","unstructured":"Kazaure HS, Roman SA, Sosa JA. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients. Ann Surg Oncol. 2012;19:1874\u201380. https:\/\/doi.org\/10.1245\/s10434-011-2129-x.","journal-title":"Ann Surg Oncol"},{"key":"845_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.821958","volume":"12","author":"Y Cui","year":"2022","unstructured":"Cui Y, Liu Y, Mu L, Li Y, Wu G. Transcriptional expressions of ALDH1A1\/B1 as independent indicators for the survival of thyroid cancer patients. Front Oncol. 2022;12:821958. https:\/\/doi.org\/10.3389\/fonc.2022.821958.","journal-title":"Front Oncol"}],"container-title":["EJNMMI Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40658-026-00845-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40658-026-00845-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40658-026-00845-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:13:01Z","timestamp":1786954381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40658-026-00845-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1186\/s40658-026-00845-9","relation":{},"ISSN":["2197-7364"],"issn-type":[{"value":"2197-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Affiliation 3 has been updated","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study involving human participants were reviewed and approved by the Ethics Committee of the Third Bethune Hospital of Jilin University (license no.2021-KYLL-030005). The patients\/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25"}}